266 related articles for article (PubMed ID: 19912308)
1. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
[TBL] [Abstract][Full Text] [Related]
2. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD;
Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
[TBL] [Abstract][Full Text] [Related]
3. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
4. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
[TBL] [Abstract][Full Text] [Related]
5. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia.
Güneş A; Ece A; Aktar F; Tan İ; Söker M; Karabel D; Balık H; Uluca Ü; Şen V; Yolbaş İ
Med Sci Monit; 2015 Dec; 21():4023-9. PubMed ID: 26697893
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
7. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
8. Glomerular and tubular damage markers are elevated in patients with diabetes.
Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT
Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
[TBL] [Abstract][Full Text] [Related]
9. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
[TBL] [Abstract][Full Text] [Related]
10. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
Panduru NM; Sandholm N; Forsblom C; Saraheimo M; Dahlström EH; Thorn LM; Gordin D; Tolonen N; Wadén J; Harjutsalo V; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
[TBL] [Abstract][Full Text] [Related]
11. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
[TBL] [Abstract][Full Text] [Related]
12. Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion.
Ichikawa D; Kamijo-Ikemori A; Sugaya T; Ohata K; Hisamichi M; Hoshino S; Kimura K; Shibagaki Y
Nephrology (Carlton); 2018 Apr; 23(4):308-316. PubMed ID: 28063188
[TBL] [Abstract][Full Text] [Related]
13. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Foster MC; Coresh J; Bonventre JV; Sabbisetti VS; Waikar SS; Mifflin TE; Nelson RG; Grams M; Feldman HI; Vasan RS; Kimmel PL; Hsu CY; Liu KD;
Clin J Am Soc Nephrol; 2015 Nov; 10(11):1956-63. PubMed ID: 26350438
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S
PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279
[TBL] [Abstract][Full Text] [Related]
15. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
16. Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.
Hirowatari K; Kawano N
Int Urol Nephrol; 2023 Aug; 55(8):2111-2118. PubMed ID: 36840803
[TBL] [Abstract][Full Text] [Related]
17. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.
Kamijo A; Kimura K; Sugaya T; Yamanouchi M; Hikawa A; Hirano N; Hirata Y; Goto A; Omata M
J Lab Clin Med; 2004 Jan; 143(1):23-30. PubMed ID: 14749682
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients.
Kamijo-Ikemori A; Sugaya T; Yasuda T; Kawata T; Ota A; Tatsunami S; Kaise R; Ishimitsu T; Tanaka Y; Kimura K
Diabetes Care; 2011 Mar; 34(3):691-6. PubMed ID: 21273494
[TBL] [Abstract][Full Text] [Related]
19. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
[TBL] [Abstract][Full Text] [Related]
20. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
